US Physical Therapy Files 8-K on Nov 6 Event

Ticker: USPH · Form: 8-K · Filed: Nov 8, 2024 · CIK: 885978

Sentiment: neutral

Topics: 8-K, disclosure, financials

Related Tickers: USPHY

TL;DR

USPHY filed an 8-K on Nov 8 for a Nov 6 event, covering Reg FD and financials.

AI Summary

U.S. Physical Therapy, Inc. filed an 8-K on November 8, 2024, reporting an event on November 6, 2024. The filing pertains to Regulation FD Disclosure and Financial Statements and Exhibits. The company, incorporated in Nevada with its principal executive offices in Houston, Texas, is involved in health services.

Why It Matters

This filing provides important updates and disclosures regarding U.S. Physical Therapy's operations and financial reporting, which could impact investor understanding of the company's current status.

Risk Assessment

Risk Level: low — The filing is a standard 8-K report for disclosures and exhibits, not indicating any immediate operational or financial distress.

Key Numbers

Key Players & Entities

FAQ

What specific event occurred on November 6, 2024, that necessitated this 8-K filing?

The filing indicates an event occurred on November 6, 2024, but the specific details of this event are not provided in the provided text, only that it is related to Regulation FD Disclosure and Financial Statements and Exhibits.

What is the primary business of U.S. Physical Therapy, Inc.?

U.S. Physical Therapy, Inc. is involved in health services, as indicated by its Standard Industrial Classification code.

Where are the principal executive offices of U.S. Physical Therapy, Inc. located?

The principal executive offices are located at 1300 West Sam Houston Parkway, Suite 300, Houston, Texas 77043.

What is the fiscal year end for U.S. Physical Therapy, Inc.?

The fiscal year end for U.S. Physical Therapy, Inc. is December 31.

What is the SEC file number for U.S. Physical Therapy, Inc.?

The SEC file number for U.S. Physical Therapy, Inc. is 001-11151.

Filing Stats: 565 words · 2 min read · ~2 pages · Grade level 10.4 · Accepted 2024-11-08 16:24:08

Filing Documents

01 Regulation FD Disclosure

ITEM 7.01 Regulation FD Disclosure. On November 6, 2024, U.S. Physical Therapy (the "Company") hosted a conference call and webcast to discuss its results for the third quarter and nine months ended Septemebr 30, 2024. The transcript of the conference call is furnished as Exhibit 99.1 to this Current Report on Form 8-K. The Company updated its investor presentation and is furnished as Exhibit 99.2 to this Current Report on Form 8-K. The presentation covers an overview of the Company and is also available on the Company's website at www.usph.com. The information in this Current Report on Form 8-K, including the exhibits, shall not be deemed to be "filed" for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), or otherwise subject to the liabilities of that section, and shall not be incorporated by reference into any registration statement or other document filed under the Securities Act of 1933, as amended, or the Exchange Act, except as shall be expressly set forth by specific reference in such filing.

01 FINANCIAL STATEMENTS AND EXHIBITS

ITEM 9.01 FINANCIAL STATEMENTS AND EXHIBITS Exhibits Description of Exhibits 99.1 Registrant's November 6, 2024 Conference Call Transcript Discussing Third Quarter and Nine Months Ended September 30, 2024 99.2 Investor Presentation for Q3 2024 SIGNATURE Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. U.S. PHYSICAL THERAPY, INC. Dated: November 8, 2024 By: /s/ CAREY HENDRICKSON Carey Hendrickson Chief Financial Officer (duly authorized officer and principal financial and accounting officer)

View Full Filing

View this 8-K filing on SEC EDGAR

View on Read The Filing